The Akt/tuberin/mTOR pathway regulates DNA damage and repair mechanisms, potentially exposing diabetic kidneys to RCC development of renal cell carcinoma (Habib and Liang, 2014). This evidence concerns the gene AKT1 and renal cell carcinoma.